Playback speed
10 seconds
ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunotherapy in Unresectable HCC
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Lorenza Rimassa
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Lorenza Rimassa
140 views
September 20, 2024
Login to view comments.
Click here to Login